CLINICAL_TRIALS
trial_result
· 2014-02-28
Clinical Trial Update: Superiority of ArTiMist Versus Quinine in Children With Severe Malaria [Phase 3]
Summary
A Phase 3 trial reports that ArTiMist is superior to quinine in treating children with severe Plasmodium falciparum malaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Proto Pharma Ltd | Conditions: Plasmodium Falciparum Malaria | Phase 3 | Status: COMPLETED | Results posted: 2014-02-28